Literature DB >> 19332797

The RCAN carboxyl end mediates calcineurin docking-dependent inhibition via a site that dictates binding to substrates and regulators.

Sara Martínez-Martínez1, Lali Genescà, Antonio Rodríguez, Alicia Raya, Eulàlia Salichs, Felipe Were, María Dolores López-Maderuelo, Juan Miguel Redondo, Susana de la Luna.   

Abstract

Specificity of signaling kinases and phosphatases toward their targets is usually mediated by docking interactions with substrates and regulatory proteins. Here, we characterize the motifs involved in the physical and functional interaction of the phosphatase calcineurin with a group of modulators, the RCAN protein family. Mutation of key residues within the hydrophobic docking-cleft of the calcineurin catalytic domain impairs binding to all human RCAN proteins and to the calcineurin interacting proteins Cabin1 and AKAP79. A valine-rich region within the RCAN carboxyl region is essential for binding to the docking site in calcineurin. Although a peptide containing this sequence compromises NFAT signaling in living cells, it does not inhibit calcineurin catalytic activity directly. Instead, calcineurin catalytic activity is inhibited by a motif at the extreme C-terminal region of RCAN, which acts in cis with the docking motif. Our results therefore indicate that the inhibitory action of RCAN on calcineurin-NFAT signaling results not only from the inhibition of phosphatase activity but also from competition between NFAT and RCAN for binding to the same docking site in calcineurin. Thus, competition by substrates and modulators for a common docking site appears to be an essential mechanism in the regulation of Ca(2+)-calcineurin signaling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19332797      PMCID: PMC2669349          DOI: 10.1073/pnas.0812544106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  A second calcineurin binding site on the NFAT regulatory domain.

Authors:  S Park; M Uesugi; G L Verdine
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

2.  Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy.

Authors:  Rick B Vega; Beverly A Rothermel; Carla J Weinheimer; Atilla Kovacs; R H Naseem; Rhonda Bassel-Duby; R S Williams; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-06       Impact factor: 11.205

3.  Identification and characterization of a highly conserved calcineurin binding protein, CBP1/calcipressin, in Cryptococcus neoformans.

Authors:  J Görlach; D S Fox; N S Cutler; G M Cox; J R Perfect; J Heitman
Journal:  EMBO J       Date:  2000-07-17       Impact factor: 11.598

4.  A conserved family of calcineurin regulators.

Authors:  T J Kingsbury; K W Cunningham
Journal:  Genes Dev       Date:  2000-07-01       Impact factor: 11.361

5.  A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling.

Authors:  B Rothermel; R B Vega; J Yang; H Wu; R Bassel-Duby; R S Williams
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

6.  DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways.

Authors:  J J Fuentes; L Genescà; T J Kingsbury; K W Cunningham; M Pérez-Riba; X Estivill; S de la Luna
Journal:  Hum Mol Genet       Date:  2000-07-01       Impact factor: 6.150

7.  Novel human ZAKI-4 isoforms: hormonal and tissue-specific regulation and function as calcineurin inhibitors.

Authors:  Xia Cao; Fukushi Kambe; Takashi Miyazaki; Devanand Sarkar; Sachiko Ohmori; Hisao Seo
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

8.  Mapping the protein phosphatase-2B anchoring site on AKAP79. Binding and inhibition of phosphatase activity are mediated by residues 315-360.

Authors:  Mark L Dell'Acqua; Kimberly L Dodge; Steven J Tavalin; John D Scott
Journal:  J Biol Chem       Date:  2002-09-26       Impact factor: 5.157

9.  The threshold pattern of calcineurin-dependent gene expression is altered by loss of the endogenous inhibitor calcipressin.

Authors:  Sandra Ryeom; Rebecca J Greenwald; Arlene H Sharpe; Frank McKeon
Journal:  Nat Immunol       Date:  2003-08-17       Impact factor: 25.606

10.  Multiple domains of MCIP1 contribute to inhibition of calcineurin activity.

Authors:  Rick B Vega; John Yang; Beverly A Rothermel; Rhonda Bassel-Duby; R Sanders Williams
Journal:  J Biol Chem       Date:  2002-06-12       Impact factor: 5.157

View more
  26 in total

Review 1.  Coding Molecular Determinants of Thyroid Cancer Development and Progression.

Authors:  Veronica Valvo; Carmelo Nucera
Journal:  Endocrinol Metab Clin North Am       Date:  2018-12-23       Impact factor: 4.741

Review 2.  Calcineurin signaling in the heart: The importance of time and place.

Authors:  Valentina Parra; Beverly A Rothermel
Journal:  J Mol Cell Cardiol       Date:  2016-12-20       Impact factor: 5.000

3.  Quercetin targets the interaction of calcineurin with LxVP-type motifs in immunosuppression.

Authors:  Yane Zhao; Jin Zhang; Xiaoyu Shi; Jing Li; Rui Wang; Ruiwen Song; Qun Wei; Huaibin Cai; Jing Luo
Journal:  Biochimie       Date:  2016-04-22       Impact factor: 4.079

4.  RCAN1-4 is a thyroid cancer growth and metastasis suppressor.

Authors:  Chaojie Wang; Motoyasu Saji; Steven E Justiniano; Adlina Mohd Yusof; Xiaoli Zhang; Lianbo Yu; Soledad Fernández; Paul Wakely; Krista La Perle; Hiroshi Nakanishi; Neal Pohlman; Matthew D Ringel
Journal:  JCI Insight       Date:  2017-03-09

5.  Regulation of RCAN1 protein activity by Dyrk1A protein-mediated phosphorylation.

Authors:  Min-Su Jung; Jung-Hwa Park; Young Shin Ryu; Sun-Hee Choi; Song-Hee Yoon; Mi-Yang Kwen; Ji Youn Oh; Woo-Joo Song; Sul-Hee Chung
Journal:  J Biol Chem       Date:  2011-09-30       Impact factor: 5.157

6.  Regulator of calcineurin 1 modulates expression of innate anxiety and anxiogenic responses to selective serotonin reuptake inhibitor treatment.

Authors:  Charles A Hoeffer; Helen Wong; Peter Cain; Josien Levenga; Kiriana K Cowansage; Yoon Choi; Camille Davy; Neil Majmundar; D Randy McMillan; Beverly A Rothermel; Eric Klann
Journal:  J Neurosci       Date:  2013-10-23       Impact factor: 6.167

Review 7.  Interaction of calcineurin with substrates and targeting proteins.

Authors:  Huiming Li; Anjana Rao; Patrick G Hogan
Journal:  Trends Cell Biol       Date:  2010-11-04       Impact factor: 20.808

8.  Splice cassette II of Na+,HCO3(-) cotransporter NBCn1 (slc4a7) interacts with calcineurin A: implications for transporter activity and intracellular pH control during rat artery contractions.

Authors:  Andreas A Danielsen; Mark D Parker; Soojung Lee; Walter F Boron; Christian Aalkjaer; Ebbe Boedtkjer
Journal:  J Biol Chem       Date:  2013-02-04       Impact factor: 5.157

9.  A novel peptide exerts potent immunosuppression by blocking the two-site interaction of NFAT with calcineurin.

Authors:  Lu Wang; Na Cheng; Ping Wang; Jing Li; Anna Jia; Wenying Li; Nan Zhang; Yanxia Yin; Li Tong; Qun Wei; Guangwei Liu; Zhimei Li; Jing Luo
Journal:  J Biol Chem       Date:  2020-01-15       Impact factor: 5.157

10.  Novel inhibitors of the calcineurin/NFATc hub - alternatives to CsA and FK506?

Authors:  Matthias Sieber; Ria Baumgrass
Journal:  Cell Commun Signal       Date:  2009-10-27       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.